COMMUNIQUÉS West-GlobeNewswire

AMN Healthcare Launches WorkWise: A Comprehensive Workforce Management & Talent Sourcing Technology

02/10/2024 - 16:05

Addresses staffing efficiency, enhances financial planning, and improves operational efficiency in healthcare systems through all-in-one technology solution to manage internal and external talent. DALLAS, Oct. 02, 2024 [...]

National Association of Dental Plans Celebrates 35th Anniversary

02/10/2024 - 16:00

NADP Marks Successes as Recognized Representative and Resource of Dental Benefits Industry DALLAS, Oct. 02, 2024 (GLOBE NEWSWIRE) -- The National Association of Dental Plans (NADP) proudly commemorates its 35 th [...]

Immix Biopharma Advances CAR-T NXC-201 to Expansion Cohort Dose Level in U.S. AL Amyloidosis Trial NEXICART-2

02/10/2024 - 15:32

Now dosing at dose expansion level of 450 million NXC-201 CAR+T cells. First cohort at 150 million CAR+T cells already successfully completed Each of these two doses have produced complete responses in prior clinical [...]

IntelGenx is Granted Court Approval of the Sale Proposal from atai Life Sciences AG

02/10/2024 - 15:21

MONTRÉAL, Oct. 02, 2024 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (the “ Company ” or “ IntelGenx ”), a leading drug delivery company focused on the development and manufacturing of pharmaceutical films, [...]

PharmAla to supply Harvard Medical School’s Maclean Hospital with LaNeo MDMA

02/10/2024 - 15:20

TORONTO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of [...]

Longeveron® to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

02/10/2024 - 15:05

MIAMI, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related [...]

Eliem Therapeutics Announces Rebranding and Corporate Name Change to Climb Bio, Inc.

02/10/2024 - 15:00

Name change to "Climb Bio" marks the Company’s transition and focus on developing treatments for immune-mediated diseases Climb Bio will begin trading on Nasdaq under the trading symbol "CLYM" effective October 3rd [...]

EVerZom achieves first bioproduction of clinical grade stem cell-derived exosomes in large scale bioreactors in partnership with the French Blood Establishment (EFS) with unprecedented yields

02/10/2024 - 15:00

EVerZom achieves first bioproduction of clinical grade stem cell-derived exosomes in large scale bioreactors in partnership with the French Blood Establishment (EFS) with unprecedented yields The disruptive, proprietary [...]

Medigene will Present at ASGCT 2024 and Host R&D Event

02/10/2024 - 15:00

Planegg/Martinsried, October 2, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor (TCR)-guided therapies [...]

DepYmed to Present at the 9th World Rett Syndrome Congress

02/10/2024 - 15:00

FARMINGDALE, N.Y., Oct. 02, 2024 (GLOBE NEWSWIRE) -- DepYmed, Inc. (“DepYmed” or the “Company”) is a clinical-stage pharmaceutical company focused on developing transformative medicines for many poorly treated diseases [...]

Reviva to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

02/10/2024 - 14:30

CUPERTINO, Calif., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet [...]

Femasys Receives Second Order from Spain Partners After Successfully Completing Commercial FemaSeed® Infertility Treatments

02/10/2024 - 14:30

ATLANTA, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of in-office, accessible, [...]

OneMedNet Announces Board Member Transition to Drive Growth Post-IPO

02/10/2024 - 14:30

MINNEAPOLIS, Oct. 02, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade Real World Data (RWD), is pleased to announce a strategic [...]

Annovis Bio Inc. (NYSE: ANVS) Research Points to Potential Future Breakthroughs in AD Space Through Innovative Combinations

02/10/2024 - 14:30

NEW YORK, Oct. 02, 2024 (GLOBE NEWSWIRE) -- via InvestorWire — Annovis Bio Inc. (NYSE: ANVS) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 60+ brands within the Dynamic Brand [...]

Vision Sensing Acquisition Corp. Announces Intention to Extend the Period to Consummate Its Initial Business Combination to November 3, 2024

01/10/2024 - 22:40

NEW YORK, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “ Company ”) a special purpose acquisition company, announced today that it has notified Continental Stock [...]

Pliant Therapeutics Appoints Gary Palmer, M.D. as Senior Vice President of Medical Affairs

01/10/2024 - 22:35

Former Bristol Myers Squibb Global Medical Affairs Lead brings over 25 years of experience to Pliant SOUTH SAN FRANCISCO, Calif., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage [...]

BioAge Labs Announces Closing of Initial Public Offering, Full Exercise of Underwriters’ Option to Purchase Additional Shares and Closing of the Concurrent Private Placement

01/10/2024 - 22:30

RICHMOND, Calif., Oct. 01, 2024 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (“BioAge”) (Nasdaq: BIOA), a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as [...]

Gyre Therapeutics to Present at 8th Annual H.C. Wainwright MASH Investor Conference

01/10/2024 - 22:05

SAN DIEGO, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), a self-sustainable, commercial-stage biotechnology company with clinical development programs focusing on a variety of chronic [...]

BrightSpring Health Services, Inc. to Announce Third Quarter 2024 Financial Results on November 1, 2024

01/10/2024 - 22:05

LOUISVILLE, Ky., Oct. 01, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its third quarter 2024 financial results on [...]